2025

January - Song S, Zilverstand A, Gui W, Pan X, Zhou X. Reducing craving and consumption in individuals with drug addiction, obesity or overeating through neuromodulation intervention: a systematic review and meta-analysis of its follow-up effects. Addiction. 2022 May;117(5):1242-1255. doi: 10.1111/add.15686. Epub 2021 Oct 21. PMID: 34514666

February - Gillving C, Ekman CJ, Hammar Å, et al. Seizure Duration and Electroconvulsive Therapy in Major Depressive Disorder. JAMA Netw Open. 2024;7(7):e2422738. doi:10.1001/jamanetworkopen.2024.22738

2024

January - Deng Z, Luber B, McClintock SM, Weiner RD, Husain MM, Lisanby SH. Clinical Outcomes of Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode: A Randomized Clinical Trial. JAMA Psychiatry. 2024;81(3):240–249. doi:10.1001/jamapsychiatry.2023.4599

February - Fineberg, Sarah K et al. “A pilot randomized controlled trial of ketamine in Borderline Personality Disorder.” Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol. 48,7 (2023): 991-999. doi:10.1038/s41386-023-01540-4

Porter, Richard J et al. “Cognitive side-effects of electroconvulsive therapy: what are they, how to monitor them and what to tell patients.” BJPsych open vol. 6,3 e40. 17 Apr. 2020, doi:10.1192/bjo.2020.17

March - Kokdere, Fatih et al. “Do deviations from the 5 sessions per week schedule impact outcomes of transcranial magnetic stimulation for major depressive disorder?.” Brain stimulation vol. 13,6 (2020): 1491-1493. doi:10.1016/j.brs.2020.08.001

Watt, Christine L et al. “Accelerated rTMS for existential distress in palliative care: A report of two cases.” Brain stimulation vol. 15,1 (2022): 197-200. doi:10.1016/j.brs.2021.12.006

April - Romo-Nava, F., Awosika, O.O., Basu, I. et al. Effect of non-invasive spinal cord stimulation in unmedicated adults with major depressive disorder: a pilot randomized controlled trial and induced current flow pattern. Mol Psychiatry 29, 580–589 (2024). https://doi.org/10.1038/s41380-023-02349-9

Gill, J.L., Schneiders, J.A., Stangl, M. et al. A pilot study of closed-loop neuromodulation for treatment-resistant post-traumatic stress disorder. Nat Commun 14, 2997 (2023). https://doi.org/10.1038/s41467-023-38712-1

May - Bedder M, Parker L. Magnetic Peripheral Nerve Stimulation (mPNS) for Chronic Pain. J Pain Res. 2023;16:2365-2373 https://doi.org/10.2147/JPR.S409331

June - Oathes, D.J., Duprat, R.JP., Reber, J. et al. Non-invasively targeting, probing and modulating a deep brain circuit for depression alleviation. Nat. Mental Health 1, 1033–1042 (2023). https://doi.org/10.1038/s44220-023-00165-2 

July - Glue, P., Loo, C., Fam, J. et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med 30, 2004–2009 (2024). https://doi.org/10.1038/s41591-024-03063-x

August - VNS candidate case presentation by Dr. Anthony Purgianto

September - 4th Annual Interventional Psychiatry Bootcamp

October - no presentation

November - Siddiqi SH, Philip NS, Palm ST, et al. A potential target for noninvasive neuromodulation of PTSD symptoms derived from focal brain lesions in veterans. Nat Neurosci. Published online September 24, 2024. doi:10.1038/s41593-024-01772-7 

December - Swartz, Conrad M. “What Is Brain Damage and Does Electroconvulsive Therapy Cause It?.” The journal of ECT vol. 40,2 (2024: 72-77. doi:10.1097/YCT.0000000000001019 

2023

January - Croarkin, Paul E et al. “Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial.” Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol. 46,2 (2021): 462-469. doi:10.1038/s41386-020-00829-y

February - No presentation

March - Ge, Ruiyang et al. “Predictive Value of Acute Neuroplastic Response to rTMS in Treatment Outcome in Depression: A Concurrent TMS-fMRI Trial.” The American journal of psychiatry vol. 179,7 (2022): 500-508. doi:10.1176/appi.ajp.21050541

April - Menon V, Varadharajan N, Faheem A, Andrade C. Ketamine vs Electroconvulsive Therapy for Major Depressive Episode: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2023;80(6):639–642. doi:10.1001/jamapsychiatry.2023.0562

May - Frick, Andreas et al. “Habitual caffeine consumption moderates the antidepressant effect of dorsomedial intermittent theta-burst transcranial magnetic stimulation.” Journal of psychopharmacology (Oxford, England) vol. 35,12 (2021): 1536-1541. doi:10.1177/02698811211058975

June - Anand, Amit et al. “Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.” The New England journal of medicine vol. 388,25 (2023): 2315-2325. doi:10.1056/NEJMoa2302399

July - Mitra, Anish et al. “Targeted neurostimulation reverses a spatiotemporal biomarker of treatment-resistant depression.” Proceedings of the National Academy of Sciences of the United States of America vol. 120,21 (2023): e2218958120. doi:10.1073/pnas.2218958120

August - No presentation

September - Shanok, Nathaniel A et al. “Deep transcranial magnetic stimulation alters resting-state neurophysiological traits in major depressive disorder.” Journal of affective disorders vol. 337 (2023): 104-111. doi:10.1016/j.jad.2023.05.066

October - Prentice, Amourie et al. “1Hz right orbitofrontal TMS benefits depressed patients unresponsive to dorsolateral prefrontal cortex TMS.” Brain stimulation vol. 16,6 (2023): 1572-1575. doi:10.1016/j.brs.2023.10.005

November - No presentation

December - No presentation

2022

February - Harel, Maayan et al. “Repetitive Transcranial Magnetic Stimulation in Alcohol Dependence: A Randomized, Double-Blind, Sham-Controlled Proof-of-Concept Trial Targeting the Medial Prefrontal and Anterior Cingulate Cortices.” Biological psychiatry vol. 91,12 (2022): 1061-1069. doi:10.1016/j.biopsych.2021.11.020

March - No presentation

April - Sundsted, Karna K et al. “Preanesthesia medical evaluation for electroconvulsive therapy: a review of the literature.” The journal of ECT vol. 30,1 (2014): 35-42. doi:10.1097/YCT.0b013e3182a3546f

May - No presentation

June - No presentation

July - Abbar, Mocrane et al. “Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial.” BMJ (Clinical research ed.) vol. 376 e067194. 2 Feb. 2022, doi:10.1136/bmj-2021-067194

August - Wachtel, L E. “Treatment of catatonia in autism spectrum disorders.” Acta psychiatrica Scandinavica vol. 139,1 (2019): 46-55. doi:10.1111/acps.12980

September - No presentation

October - Price, Rebecca B et al. “A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant Effect of a Single Ketamine Infusion: A Randomized Clinical Trial.” The American journal of psychiatry vol. 179,12 (2022): 959-968. doi:10.1176/appi.ajp.20220216

November - Cole, Jaeden et al. “Efficacy of Adjunctive D-Cycloserine to Intermittent Theta-Burst Stimulation for Major Depressive Disorder: A Randomized Clinical Trial.” JAMA psychiatry vol. 79,12 (2022): 1153-1161. doi:10.1001/jamapsychiatry.2022.3255

December - Goodwin, Guy M et al. “Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.” The New England journal of medicine vol. 387,18 (2022): 1637-1648. doi:10.1056/NEJMoa2206443